Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 3
Submit an article Journal homepage
305
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Pretransplant serum ferritin has a prognostic influence on allogeneic transplant regardless of disease risk

Takayoshi TachibanaDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan;Department of Hematology, Yokohama City University Medical Center, Yokohama, JapanCorrespondence[email protected]
,
Masatsugu TanakaDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan
,
Ayumi NumataDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan
,
Hirotaka TakasakiDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan
,
Satomi ItoDepartment of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
,
Rika OhshimaDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan
,
Maki HagiharaDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan
,
Etsuko YamazakiDepartment of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
,
Naoto TomitaDepartment of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
,
Katsumichi FujimakiDepartment of Hematology/Immunology, Fujisawa City Hospital, Fujisawa, Japan
,
Jun TaguchiDepartment of Hematology, Shizuoka Red Cross Hospital, Shizuoka, Japan
,
Rika SakaiDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan
,
Hiroyuki FujitaDepartment of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
,
Shin FujisawaDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan
,
Atsuo MarutaDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan
,
Yoshiaki IshigatsuboDepartment of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
&
Heiwa KanamoriDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan
 show all
Pages 456-461 | Received 25 May 2011, Accepted 29 Aug 2011, Published online: 24 Oct 2011

References

  • Armand P, Kim HT, Cutler CS, . Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007;109:4586–4588.
  • Pullarkat V, Blanchrd S, Tegtmeier B, . Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2008;42:799–805.
  • Kataoka K, Nannya Y, Hangaishi A, . Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009;15:195–204.
  • Mahindra A, Bolwell B, Sobecks R, . Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation. Br J Haematol 2009;146: 310–316.
  • Maradei SC, Maiolono A, de Azevedo AM, . Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. Blood 2009;114:1270–1275.
  • Rubinstein P, Carrier C, Scaradavou A, . Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565–1577.
  • Armand P, Kim HT, Cutler CS, . A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2008;14:28–35.
  • Tachibana T, Takasaki H, Tanaka M, . Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome. Bone Marrow Transplant 2011;46:150–151.
  • Wahlin A, Lorenz F, Fredriksson M, . Hyperferritinemia is associated with low incidence of graft versus host disease, high relapse rate, and impaired survival in patients with blood disorders receiving allogeneic hematopoietic stem cell grafts. Med Oncol 2010;28:552–558.
  • Fujimaki K, Taguchi J, Fujita H, . Thiotepa/cyclophosphamide/TBI as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome. Bone Marrow Transplant 2004;33:789–792.
  • Przepiorka D, Weisdorf D, Martin P, . Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995;15:825–828.
  • Armand P. Further analysis of the relationship between pretransplantation serum ferritin and transplantation outcome: cause-of-death analysis and impact of disease duration. Blood 2007;110: 3083–3084.
  • Armand P, Kim HT, Rhodes J, . Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation. Biol Blood Marrow Transplant 2010;17:852–860.
  • Ferrá C, Sanz J, de la Cámara R, .; GETH (Grupo Español de Trasplante Hematopoyético) and PETHEMA (Programa Español de Tratamiento en Hematología), Spanish Society of Hematology. Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source. Biol Blood Marrow Transplant 2010;16:957–966.
  • Tachibana T, Tanaka M, Takasaki H, . Pre-SCT serum ferritin is a prognostic factor in adult AML, but not ALL. Bone Marrow Transplant 2011;46:1268–1269.
  • Pullarkat V. Iron overload in patients undergoing hematopoietic stem cell transplantation. Adv Hematol 2010;2010. pii:345756.
  • Alessandrino EP, Della Porta MG, Bacigalupo A, . Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica 2010;95:476–484.
  • Lee JW, Kang HJ, Kim EK, . Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children. Bone Marrow Transplant 2009;44:793–797.
  • Kaloyannidis P, Yannaki E, Sakellari I, . The impact of desferrioxamine postallogeneic hematopoietic cell transplantation in relapse incidence and disease-free survival: a retrospective analysis. Transplantation 2010;89:472–479.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.